Skip to main content
Robert Molinari, MD, Orthopaedic Surgery, Rochester, NY

RobertWMolinariMD

Orthopaedic Surgery Rochester, NY

Orthopedic Spine Surgery, Orthopedic Trauma

Professor, Orthopaedics and Neurosurgery, University of Rochester School of Medicine & Dentistry

Dr. Molinari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Molinari's full profile

Already have an account?

  • Office

    601 Elmwood Ave
    # 665
    Rochester, NY 14642
    Phone+1 585-275-1733
    Fax+1 585-756-4726

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Orthopaedic Surgery Of The Spine, 1997 - 1998
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Orthopaedic Surgery, 1989 - 1993
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1988 - 1989
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1988

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2003 - Present
  • NY State Medical License
    NY State Medical License 1989 - 2026
  • American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Press Mentions

  • Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington's Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate
    Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington's Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug CandidateJuly 9th, 2018
  • US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)
    US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)April 29th, 2020